Sensorion - Public Comps and Valuation Multiples

Sensorion Overview

About Sensorion

Sensorion SA is a France-based clinical-stage biotech company dedicated to developing therapies to restore, treat, and prevent hearing loss. The company's product is in phase 2a clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies. The Company does business in a single operating segment: conducting research and development to discover drugs to treat inner ear disorders with a view to their future marketing. The company's pipeline programs are SENS-401 SSNHL, SENS-401 CIO, GJB2-GT, GJB2-GT, SENS-401 Cochlear, and others.

Founded

2010

HQ

Employees

Website

sensorion.com

Sectors

Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $13.5M

LTM EBITDA -$37.7M

EV

$65.6M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Sensorion Financials

As of September 2025, Sensorion reported last 12-month revenue of $13.5M and EBITDA of -$37.7M.

In the same period, Sensorion achieved -$34.9M in LTM net income.

See Sensorion valuation multiples based on analyst estimates

Sensorion P&L

In the most recent fiscal year, Sensorion reported EBITDA of -$29.4M.

Sensorion expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Sensorion valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$13.5M	XXX	n/a	XXX	XXX	XXX
Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
Gross Margin	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA	-$37.7M	XXX	-$29.4M	XXX	XXX	XXX
EBITDA Margin	-279%	XXX	n/a	XXX	XXX	XXX
EBIT	-$29.6M	XXX	-$32.8M	XXX	XXX	XXX
EBIT Margin	-218%	XXX	n/a	XXX	XXX	XXX
Net Profit	-$34.9M	XXX	-$30.0M	XXX	XXX	XXX
Net Margin	-258%	XXX	n/a	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Sensorion including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $13.5M. EBITDA for the last twelve months was -$37.7M.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$13.5M	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$37.7M	Analyst estimates available to subscribers	-$29.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-278.8% EBITDA margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$29.6M	Analyst estimates available to subscribers	-$32.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-218.5% EBIT margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$34.9M	Analyst estimates available to subscribers	-$30.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-257.6% net profit margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Sensorion

This financial data table provides comprehensive performance metrics for Sensorion, a company based in France. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Sensorion generated $13.5M in revenue over the last twelve months.
The company achieved -$37.7M in EBITDA over the last twelve months.
Net income over the last twelve months reached -$34.9M.

Fiscal Year Performance

Fiscal year EBITDA was -$29.4M.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Sensorion. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Sensorion Stock Performance

Sensorion has current market cap of EUR 112M (or $130M), and EV of EUR 56.7M (or $65.6M).

Market Cap Evolution

Sensorion Stock Data

As of October 17, 2025, Sensorion's stock price is EUR 0 (or $0).

See Sensorion trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$65.6M	$130M	XXX	XXX	XXX	XXX	$-0.09

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Sensorion Valuation Multiples

Sensorion's trades at 288.5x EV/Revenue multiple, and -2.2x EV/EBITDA.

See valuation multiples for Sensorion and 15K+ public comps

Sensorion Financial Valuation Multiples

As of October 17, 2025, Sensorion has market cap of $130M and EV of $65.6M.

Equity research analysts estimate Sensorion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Sensorion has a P/E ratio of -3.7x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$130M	XXX	$130M	XXX	XXX	XXX
EV (current)	$65.6M	XXX	$65.6M	XXX	XXX	XXX
EV/Revenue	4.8x	XXX	288.5x	XXX	XXX	XXX
EV/EBITDA	-1.7x	XXX	-2.2x	XXX	XXX	XXX
EV/EBIT	-2.2x	XXX	-2.0x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	-3.7x	XXX	-4.3x	XXX	XXX	XXX
EV/FCF	-4.9x	XXX	-2.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Sensorion Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Sensorion Margins & Growth Rates

Sensorion's last 12 month revenue growth is 53%

Sensorion's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.5M for the same period.

Sensorion's rule of 40 is -10801% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Sensorion's rule of X is -146% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Sensorion and other 15K+ public comps

Sensorion Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	53%	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	-279%	XXX	n/a	XXX	XXX	XXX
EBITDA Growth	-29%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-10801%	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-146%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.5M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial